Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fulcrum Therapeutics Inc
(NQ:
FULC
)
8.550
-0.190 (-2.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Fulcrum Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Why Fulcrum Therapeutics Shares Are Falling
January 18, 2023
Fulcrum Therapeutics Inc (NASDAQ: FULC) shares are trading lower by 6.43% to $13.09 Wednesday morning after the company announced pricing of an upsized public offering of common stock.
Via
Benzinga
Fulcrum Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
January 17, 2023
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 17, 2023
Via
Benzinga
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
January 17, 2023
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Looking Into Fulcrum Therapeutics's Return On Capital Employed
December 06, 2022
Via
Benzinga
Recap: Fulcrum Therapeutics Q2 Earnings
August 11, 2022
Fulcrum Therapeutics (NASDAQ:FULC) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 16, 2023
Via
Benzinga
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 13, 2023
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
$3.4 Million Bet On CrowdStrike Holdings? Check Out These 3 Stocks Insiders Are Buying
January 09, 2023
Although US stocks closed sharply higher on Friday, there were a few notable insider trades.
Via
Benzinga
Fulcrum Therapeutics Provides Business Update and 2023 Outlook
January 04, 2023
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Fulcrum Therapeutics Announces CEO Transition
January 04, 2023
Robert J. Gould, Ph.D., former president and founding chief executive officer of Fulcrum, is appointed as interim CEO as Bryan Stuart departs to pursue other opportunities
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Over $13 Million Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying
December 19, 2022
Although US stocks closed lower on Friday, there were a few notable insider trades.
Via
Benzinga
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 05, 2022
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Fulcrum Therapeutics to Participate at Upcoming 2022 BofA Securities Biotech SMID Cap Conference
December 01, 2022
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 11, 2022
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Fulcrum Therapeutics Announces Recent Business Highlights and Third Quarter 2022 Financial Results
November 08, 2022
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Fulcrum Therapeutics Appoints Chief Medical Officer and Chief Scientific Officer
November 07, 2022
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Fulcrum Therapeutics Earnings Preview
November 07, 2022
Fulcrum Therapeutics (NASDAQ:FULC) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Fulcrum...
Via
Benzinga
Fulcrum Therapeutics® to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Tuesday, November 8, 2022 at 8:00 a.m. ET
November 02, 2022
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Fulcrum Therapeutics® to Participate at Upcoming November Investor Conferences
November 01, 2022
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday
October 21, 2022
Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 19, 2022
Gainers ASLAN Pharma (NASDAQ:ASLN) stock moved upwards by 13.7% to $0.54 during Wednesday's after-market session. The market value of their outstanding shares is at $37.6 million.
Via
Benzinga
Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session
October 20, 2022
Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares jumped 126% to $0.4525 after the company announced its NextFintech division received commitment for a $15 million strategic investment.
Via
Benzinga
Fulcrum Therapeutics to Present New Data from the Open Label Extension of Phase 2 ReDUX4 Study at the World Muscle Society (WMS) Congress in Halifax, Canada
October 12, 2022
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 07, 2022
From
Fulcrum Therapeutics, Inc.
Via
GlobeNewswire
U.S. Stock Futures Edge Lower Ahead Of Walmart, Home Depot Earnings
August 16, 2022
Pre-open movers
Via
Benzinga
Walmart, Home Depot And 3 Stocks To Watch Heading Into Tuesday
August 16, 2022
With US stock futures trading slightly lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Fulcrum Therapeutics Earnings Preview
August 10, 2022
Fulcrum Therapeutics (NASDAQ:FULC) is set to give its latest quarterly earnings report on Thursday, 2022-08-11. Here's what investors need to know before the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 12, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 11, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.